A Study of LY3209590 in Japanese Participants With Type 2 Diabetes

NCT03603704 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3209590
DRUG: Placebo

Sponsor

Eli Lilly and Company